Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M S Bandekar"'
Publikováno v:
International Journal of Risk & Safety in Medicine. 23:163-169
Objective To collect data on suspected adverse drug reactions of HAART therapy; analyze the data; and find out frequency of preventable adverse drug reactions in order to minimize the harm to the patients. Design Retrospective study. Methods ADR data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb041b44ab7c4bcba7f3f06bb84e7285
https://doi.org/10.3233/jrs-2011-0532
https://doi.org/10.3233/jrs-2011-0532
Publikováno v:
Indian journal of cancer. 48(1)
Background: Bevacizumab a recombinant humanized monoclonal antibody was approved in 2004 by US FDA for metastatic colorectal cancer. It is reported to cause potentially serious toxicities including severe hypertension, proteinuria, and congestive hea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::790d54e14e8156b20ad002c32474f464
https://pubmed.ncbi.nlm.nih.gov/21248449
https://pubmed.ncbi.nlm.nih.gov/21248449
Publikováno v:
Pharmacoepidemiology and drug safety. 19(11)
Adverse drug reactions (ADRs) are considered as one of the leading causes of death among hospitalized patients. Thus reporting of adverse drug reactions become an important phenomenon. Spontaneous adverse drug reaction reporting form is an essential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe6bc970a2970e7ad7429847fe01c917
https://pubmed.ncbi.nlm.nih.gov/20845409
https://pubmed.ncbi.nlm.nih.gov/20845409